Screener
Merck & Co. MRK Non-Controlling Interests
Non-Controlling Interests at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:11 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0000310158-26-000212
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Retained earnings | 63,269 | 73,075 |
| Accumulated other comprehensive loss | (3,942) | (4,287) |
| 106,065 | 115,605 | |
| Less treasury stock, at cost:1,108,460,187 shares in 2026 and 1,102,476,756 shares in 2025 | 64,132 | 62,999 |
| Total Merck & Co., Inc. stockholders’ equity | 41,933 | 52,606 |
| Noncontrolling Interests | 51 | 56 |
| Total equity | 41,984 | 52,662 |
| $129,802 | $136,866 |
Item 1. Financial Statements
FAQ
- What is Merck & Co.'s non-controlling interests?
- Merck & Co. (MRK) reported non-controlling interests of $51M in Q2 2026.
- How has Merck & Co.'s non-controlling interests changed year-over-year?
- Merck & Co.'s non-controlling interests decreased by 23.9% year-over-year, from $67M to $51M.
- What is the long-term trend for Merck & Co.'s non-controlling interests?
- Over 5 years (2020 to 2025), Merck & Co.'s non-controlling interests has grown at a -8.4% compound annual growth rate (CAGR), from $87M to $56M.
- What does non-controlling interests mean?
- Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.
Ask your AI about Merck & Co.'s non-controlling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude